Abstract

The regulation of oxygen (O2) levels is crucial in embryogenesis and adult life, as O2 controls a multitude of key cellular functions. Low oxygen levels (hypoxia) are relevant for tissue physiology as they are integral to adequate metabolism regulation and cell fate. Hence, the hypoxia response is of utmost importance for cell, organ and organism function and is dependent on the hypoxia-inducible factor (HIF) pathway. HIF pathway activity is strictly regulated by the family of oxygen-sensitive HIF prolyl hydroxylase domain (PHD) proteins. Physiologic hypoxia is a hallmark of the hematopoietic stem cell (HSC) niche in the bone marrow. This niche facilitates HSC quiescence and survival. The present review focuses on current knowledge and the many open questions regarding the impact of PHDs/HIFs and other proteins of the hypoxia pathway on the HSC niche and on normal and malignant hematopoiesis.

Highlights

  • Hematopoietic Stem Cells in the Hypoxic Bone Marrow EnvironmentHematopoiesis relies on hematopoietic stem cells (HSCs), a rare cell population in the bone marrow [1]

  • Quiescent HSCs reside within a specialized microenvironment of the bone marrow (BM), whereby HSCs are located in close vicinity to endothelial cells (ECs) [7,8], perivascular cells [7], mesenchymal stem cells [9] and megakaryocytes [10,11], which are all considered as the BM niche

  • Since the discovery of hypoxia-inducible factor (HIF) more than 25 years ago, numerous studies have described the influence of hypoxia and hypoxia response pathway proteins in various physiological and pathological processes

Read more

Summary

Introduction

Hematopoiesis (i.e., the generation of blood cells) relies on hematopoietic stem cells (HSCs), a rare cell population in the bone marrow [1]. The present review emphasizes recent advances in the role of the hypoxia response in HSPC metabolism and function as well as in the crosstalk between HSPCs and the BM niche. We here review these aspects both in the context of normal hematopoiesis/normal HSCs and hematological malignancies/leukemic stem cells (LSCs)

Hypoxia Pathway Proteins
Hypoxia Pathway Proteins in Normal Hematopoiesis
The BM Niche and Hypoxia
Hypoxia Pathway Proteins in HSC Mobilization
Hypoxia Pathway Proteins in Malignant Hematopoiesis
Findings
Concluding Remarks
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.